Literature DB >> 12002995

Migrastatin and a new compound, isomigrastatin, from Streptomyces platensis.

Elaine J Woo1, Courtney M Starks, John R Carney, Robert Arslanian, Lawrence Cadapan, Stefan Zavala, Peter Licari.   

Abstract

Streptomyces platensis (strain NRRL 18993), a producer of dorrigocins, was shown to produce migrastatin, a cyclic congener of dorrigocin A previously reported from a different organism. Additionally a new compound isomeric to migrastatin, isomigrastatin, was also isolated and its structure was determined to be a cyclic form of dorrigocin B. Both compounds were fully characterized from MS and NMR data. Product titers of both were improved by the addition of XAD-16 resin to the fermentation medium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12002995     DOI: 10.7164/antibiotics.55.141

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  25 in total

1.  Synthesis and evaluation of antimigratory and antiproliferative activities of lipid-linked [13]-macro-dilactones.

Authors:  Anniefer N Magpusao; Richard T Desmond; Katelyn J Billings; Gabriel Fenteany; Mark W Peczuh
Journal:  Bioorg Med Chem Lett       Date:  2010-07-25       Impact factor: 2.823

2.  Thermolysis of isomigrastatin and its congeners via [3,3]-sigmatropic rearrangement: a new route to the synthesis of migrastatin and its analogues.

Authors:  Jianhua Ju; Si-Kyu Lim; Hui Jiang; Jeong-Woo Seo; Yeng Her; Ben Shen
Journal:  Org Lett       Date:  2006-12-07       Impact factor: 6.005

3.  Characterization of product capture resin during microbial cultivations.

Authors:  Scott Frykman; Hiroko Tsuruta; Jorge Galazzo; Peter Licari
Journal:  J Ind Microbiol Biotechnol       Date:  2006-02-11       Impact factor: 3.346

4.  Garbled messages and corrupted translations.

Authors:  Tilman Schneider-Poetsch; Takeo Usui; Daisuke Kaida; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

Review 5.  Use of in situ solid-phase adsorption in microbial natural product fermentation development.

Authors:  Thomas Phillips; Matthew Chase; Stephanie Wagner; Chris Renzi; Marcella Powell; Joseph DeAngelo; Peter Michels
Journal:  J Ind Microbiol Biotechnol       Date:  2013-03-23       Impact factor: 3.346

6.  Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice.

Authors:  Dandan Shan; Lin Chen; Jon T Njardarson; Christoph Gaul; Xiaojing Ma; Samuel J Danishefsky; Xin-Yun Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

Review 7.  Challenges and opportunities for natural product discovery, production, and engineering in native producers versus heterologous hosts.

Authors:  Christiana N Teijaro; Ajeeth Adhikari; Ben Shen
Journal:  J Ind Microbiol Biotechnol       Date:  2018-11-13       Impact factor: 3.346

8.  Migrastatin analogues target fascin to block tumour metastasis.

Authors:  Lin Chen; Shengyu Yang; Jean Jakoncic; J Jillian Zhang; Xin-Yun Huang
Journal:  Nature       Date:  2010-04-15       Impact factor: 49.962

Review 9.  Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide a (marizomib) and other salinosporamides.

Authors:  Barbara C Potts; Kin S Lam
Journal:  Mar Drugs       Date:  2010-03-25       Impact factor: 5.118

10.  Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency.

Authors:  Jianhua Ju; Scott R Rajski; Si-Kyu Lim; Jeong-Woo Seo; Noël R Peters; F Michael Hoffmann; Ben Shen
Journal:  Bioorg Med Chem Lett       Date:  2008-07-24       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.